The agency that offers health insurance for state workers voted Thursday to stop covering GLP-1 drugs for weight loss, as Massachusetts tries to get a handle on the soaring health care costs that are squeezing the state budget
Diabetes Retatrutide has been studied in both obese adults without diabetes and patients with type 2 diabetes, and the outcomes show clear differences in how dosing impacts each population
Dysesthesia was more common in the semaglutide 7.2 mg group (18.9%) than in the semaglutide 2.4 mg group (4.9%) or the placebo group (0%), but there was no difference between the groups in frequency of serious adverse events (semaglutide 7.2 mg, 9.1%
This potential use would be informal initially, as there is very little or no formal clinical guidance on the use of pharmacotherapy to maintain weight loss, but as clinical trials have shown that people who discontinue AOMs typically regain weight, it is highly likely that real world use of these agents will include use to maintain weight loss and therefore that lower cost semaglutide may be preferred
This daily administration requires consistent adherence from the patient to achieve optimal results
In response to those reports, the European Medicines Agency conducted a review of all available data and concluded that there was no evidence of increased risk of suicidality in people using GLP-1 drugs
